Increase in reported adverse events following seasonal influenza vaccination among the French armed forces, 2008-2009: Possible role of stimulated reporting and background cases of influenza-like infection

Public Health

Volumn 126, Issue 1, 2012, Pages 70-76

  Mayet, A ^a   Nivoix, P ^b   Haus Cheymol, R ^a   De Laval, F ^b   Verret, C ^a   Duron, S ^a   Faure, N ^b   Piarroux, M ^b   Decam, C ^b   Chaudet, H ^b   Meynard, J B ^a,c   Deparis, X ^b,c   Migliani, R ^a,c  

^a SERVICE D ENDOCRINOLOGIE   (France)

^b SERVICE DE SANTÉ DES ARMÉES   (France)

^c Hôpital Inter Armées du Val de Grâce   (France)

Author keywords

Armed forces; Background case; Seasonal influenza; Vaccine adverse event

Indexed keywords

CETRIMIDE; FORMALDEHYDE; GENTAMICIN; INFLUENZA VACCINE; THIOMERSAL;

ARMED FORCES; EPIDEMIC; EPIDEMIOLOGY; HEALTH CARE; IMMUNIZATION; INFECTIOUS DISEASE; INFLUENZA; NEUROLOGY; VACCINATION; VACCINE; VIRAL DISEASE;

ALLERGIC REACTION; ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; ENCEPHALOMYELITIS; FEVER; FRANCE; GUILLAIN BARRE SYNDROME; HEADACHE; HEALTH SURVEY; HUMAN; INCIDENCE; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INJECTION SITE INFLAMMATION; KIDNEY DYSFUNCTION; MEDICAL INFORMATION SYSTEM; NEUROLOGIC DISEASE; PAIN; PANDEMIC; PATIENT INFORMATION; SEASONAL INFLUENZA; SOLDIER; UNSPECIFIED SIDE EFFECT; VASCULITIS; VIRUS INFECTION;

ADOLESCENT; ADULT; DRUG TOXICITY; FEMALE; FRANCE; HUMANS; INCIDENCE; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MILITARY PERSONNEL; SEASONS; VACCINATION; YOUNG ADULT;

FRANCE;

EID: 84155167171     PISSN: 00333506     EISSN: 14765616     Source Type: Journal    
DOI: 10.1016/j.puhe.2011.09.025     Document Type: Article

References (27)

1. Mayet A., Ligier C., Nivoix P., Berger F., Lagathu G., Pommier de Santi V., Haus-Cheymol R., Duron S., Spiegel A., Deparis X., Nicand E., Migliani R. Surveillance de la grippe saisonnière dans les armées françaises de 2004 à 2008: Système militaire d'observation de la grippe. Bull Epidemiol Hebd 2009, 34:372-376.
2. Takacs Witkop C., Duffy M.R., Macias E.A., Gibbons T.F., Escobar J.D., Burwell K.N., et al. Novel influenza A (H1N1) outbreak at the U.S. Air Force Academy. Am J Prev Med 2009, 10.1016/j.ampere.2009.10.005.
3. Nicand E., Buisson Y. Prophylaxie de la grippe. Vaccinations dans les armées 1999, 55-66. ADDIM, Paris. Y. Buisson (Ed.).
4. Piedra P.A., Gaglani M.J., Kozinetz C.A., Herschler G., Riggs M., Griffith M., et al. Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children. Vaccine 2005, 23:1540-1548.
5. Reichert T.A., Sugaya N., Fedson D.S., Glezen W.P., Simonsen L., Tashiro M. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 2001, 344:889-896.
6. Merlin M., Buisson Y. L'évaluation de l'efficacité de la vaccination antigrippale dans les armées au cours de l'hiver 1989-1990. Bull Epidemiol Hebd 1990, 41:175-176.
7. Migliani R., Dart T., Spiegel A., Maurel R., Rey J.L., Buisson Y. évaluation de l'efficacité du vaccin grippal 1995 dans une unité militaire de la région île-de-France. Bull Epidemiol Hebd 1997, 35:157-158.
8. Haus-Cheymol R., Nicand E., Buisson Y., Berger F., Decam C., Spiegel A. Evaluation de l'efficacité Clinique de la vaccination antigrippale triennale dans les armées (saison 2003-2004). Rev Epidemiol Sante Publique 2007, 55:339-345.
9. Russell K.L., Ryan M.A., Hawksworth A., Freed N.E., Irvine M., Daum L.T. NHRC Respiratory Disease Surveillance Team. Effectiveness of the 2003-2004 influenza vaccine among U.S. military basic trainees: a year of suboptimal match between vaccine and circulating strain. Vaccine 2005, 23:1981-1985.
10. Strickler J.K., Hawksworth A.W., Myers C., Irvine M., Ryan M.A., Russell K.L. Influenza vaccine effectiveness among US military basic trainees, 2005-06 season. Emerg Infect Dis 2007, 13:617-619.
11. Begaud B., Chaslerie A., Haramburu F. Organization and results of drug vigilance in France. Rev Epidemiol Sante Publique 1994, 42:416-423.
12. Stroup D.F., Wharton M., Kafadar K., Dean A.G. Evaluation of a method for detecting aberrations in public health surveillance data. Am J Epidemiol 1993, 137:373-380.
13. Vidal dictionnaire 2010, Vidal Publications, Paris.
14. ®: 25-years experience of safety and immunogenicity. Vaccine 2009, 27:2414-2417.
15. ®. Vaccine 2006, 24:1586-1592.
16. Vellozi C., Burwen D.R., Dobardzic A., Ball R., Walton K., Haber P. Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring. Vaccine 2009, 27:2114-2120.
17. Ball R., Halsey N., Braun M.M., Moulton L.H., Gale A.D., Rammohan K., et al. Development of case definitions for acute encephalopathy, encephalitis and multiple sclerosis reports to the Vaccine Adverse Event Reporting System. J Clin Epidemiol 2002, 55:819-824.
18. Souayah N., Nasar A., Suri M.F.K., Qureshi A.I. Guillain-Barre syndrome after vaccination in United States. A report from the CDC/FDA vaccine adverse event reporting system. Vaccine 2007, 25:5253-5255.
19. Emergence of a novel swine-origin influenza A(H1N1) virus in humans. N Engl J Med 2009, 360:2605-2615.
20. Mayet A., Pommier de Santi V., Manet G., Nivoix P., Ligier C., Faure N., Haus-Cheymol R., Piarroux M., Dia A., Duron S., Tanti M., De Laval F., Camara K., Queyriaux B., Nicand E., Decam C., Chaudet H., Meynard J.B., Deparis X., Migliani R. Surveillance épidémiologique de la grippe A(H1N1) 2009 dans les armées françaises: adaptation des systèmes de surveillance au contexte pandémique. Med Mal Infect 2010, 40:404-411.
21. ® reported in the French military forces - 2009-2010. Vaccine 2011, 29:2576-2581.
22. Mayet A., Duron S., Nivoix P., Haus-Cheymol R., Ligier C., Gache K., Dia A., Manet G., Verret C., Pommier de Santi V., Bigaillon C., Martinaud C., Piarroux M., Faure N., Hupin C., Tanti M., Decam C., Chaudet H., Meynard J.B., Nicand E., Deparis X., Migliani R. Novel influenza A(H1N1) outbreak among French armed forces in 2009: results of military influenza surveillance system. Public Health 2011, 125:494-500.
23. Hannoun C., Megas F., Piercy J. Immunogenicity and protective efficacy of influenza vaccination. Virus Res 2004, 103:133-138.
24. Geier M.R., Geier D.A., Zahalsky A.C. Influenza vaccination and Guillain Barre syndrome. Clin Immunol 2003, 107:116-121.
25. Ajjan N. Réactions indésirables à la vaccination. La vaccination: manuel pratique de tous les vaccins 2009, 69-84. Masson, Paris. N. Ajjan (Ed.).
26. Stowe J., Andrews N., Wise L., Miller E. Investigation of the temporal association of Guillain Barre syndrome with influenza vaccine and influenzalike illness using the United Kingdom general practice research database. Am J Epidemiol 2009, 169:382-388.
27. Black S., Eskola J., Siegrist C.-A., Halsey N., MacDonald N., Law B., Miller E., Andrews N., Stowe J., Salmon D., Vannice K., Izurieta H.S., Akhtar A., Gold M., Oselka G., Zuber P., Pfeifer D., Vellozzi C. Importance of background rates of disease in assessment of vaccine safety during mass immunization with pandemic H1N1 influenza vaccines. Lancet 2010, 374:2115-2122.